Compound E, chemically designated as the compound 209986-17-4, represents a significant exploration within the field of Alzheimer's disease research. This γ-secretase inhibitor was initially developed as a promising https://heathsdeu182521.activoblog.com/51162315/γ-secretase-blocker-compound-e-209986-17-4